EMA Authorised: Eptifibatide Accord (eptifibatide) — Accord Healthcare S.L.U.

View source ↗

Summary

Authorised in the EU: Accord Healthcare's Eptifibatide (eptifibatide) approved for use in myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Eptifibatide Accord (eptifibatide)

Snippet

Status: Authorised. Therapeutic area: Myocardial Infarction. MAH: Accord Healthcare S.L.U.. Decision date: 02/05/2025